Moderna Inc (MRNA)
Pretax margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -3,942,000 | -2,357,000 | 818,000 | 5,041,000 | 9,575,000 | 13,330,000 | 15,665,000 | 16,254,000 | 13,285,000 | 7,604,000 | 3,820,000 | 640,000 | -744,000 | -596,743 | -488,136 | -506,400 | -515,000 | -532,481 |
| Revenue (ttm) | US$ in thousands | 6,758,000 | 9,088,000 | 10,654,000 | 15,059,000 | 19,263,000 | 21,390,000 | 22,995,000 | 22,600,000 | 18,471,000 | 11,831,000 | 7,019,000 | 2,732,000 | 803,000 | 246,055 | 106,101 | 52,184 | 60,209 | 81,575 |
| Pretax margin | -58.33% | -25.94% | 7.68% | 33.47% | 49.71% | 62.32% | 68.12% | 71.92% | 71.92% | 64.27% | 54.42% | 23.43% | -92.65% | -242.52% | -460.07% | -970.41% | -855.35% | -652.75% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-3,942,000K ÷ $6,758,000K
= -58.33%
The pretax margin of Moderna Inc has exhibited significant variability over the past eight quarters, ranging from a low of -57.56% in Q4 2023 to a high of 71.92% in Q1 2022. The downward trend in pretax margin is evident, with a decrease from 49.71% in Q4 2022 to -57.56% in Q4 2023. This decline may indicate challenges in managing costs or generating sufficient revenue to cover operating expenses before taxes. The positive pretax margins in Q1 2023 and Q2 2023 suggest that the company was able to generate profits before tax during those periods. Further analysis is recommended to understand the factors driving the fluctuations in Moderna Inc's pretax margin and evaluate the company's financial performance and operational efficiency.
Peer comparison
Dec 31, 2023